InsidersTradesSigma
Ascelia Pharma AB: insider trades · Finland · FIN-FSA
FI:ascelia-pharma-abSE0010573113FI·FIN-FSAMcap 393M€Healthcare
Discover the full insider trade history of Ascelia Pharma AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Ascelia Pharma AB has logged 1 public disclosures. Market capitalisation: €393.3m. The latest transaction was reported on 23 September 2025 (Purchase). Among the most active insiders: Peter Benson. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
€4,840
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.94 €
Analyst consensus
4 analystsStrong buy
3.70 €Target 5.60 €(+90%)8.50 €
Income statement
Net income−76.3 M€0.0% margin
Valuation
PER (forward)29.4x
P/Book3.8x
Beta0.89
Balance sheet & cash
Market cap393.3 M€
Total debt970 k€
Free Cash Flow−72.3 M€
Debt / Equity1%
Profitability & ownership
ROE-100.8%
ROA-40.4%
% insiders16.7%
% institutions21.8%
Last declaration on 23 September 2025
Declarations1 total
Executives●Purchase35FIN-FSA
€4,84015,000 shares@ €0.32270.0012% mcap100.0% of flow
Aktie
FI:A003S559-1·
Ideal exit: 20 Jun 2026 (T+270)
1 of 1 declaration